CHOICE HOTELS INTERNATIONAL INC /DE — Form 8-K
Filed July 1, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Choice Hotels appointed Ali Keshavarz, President and Chief Data & Analytics Officer of CVS Health, as an independent director effective June 26, 2026, for a term expiring at the 2027 Annual Meeting. Board size increased to 12 directors. Keshavarz will receive standard non-employee director compensation; no dollar amount or equity grant disclosed. No committee assignments have been determined.
Why this rating
Routine board appointment of experienced AI/data executive with no disclosed financial consideration, equity grants, or strategic M&A/financing implications.
Extracted items
- 5.02 exec change
- 9.01 exhibits
View original filing on SEC.gov ↗
See more from July 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.